Transmutex completes its Series A shortly after its seed financing round

In July 2021, the Geneva based cleantech company Transmutex has completed its CHF 5.3 million Series A. This comes a couple months after its CHF 2.6 million seed financing round that completed in May. These financing rounds will allow Transmutex to continue its R&D activities.

Transmutex is a start-up founded in Geneva in 2019, developing a revolutionary nuclear technology for the transmutation of long-lived nuclear waste based on CERN technologies. Transmutex's solution uses particle accelerators to transmute existing long-lived nuclear waste, which, in turn, produces carbon-free energy that can be reinjected in the grid or used to produce green hydrogen. In 2020, Transmutex was awarded the public vote, in the cleantech category, at the 2020 Top 100 Swiss Startups Award organized by Venturelab.

Lenz & Staehelin is advising Transmutex in all legal aspects of its activities since its foundation.